This guideline provides recommendations to users and manufacturers of point-of-care coagulation testing devices for monitoring heparin and vitamin K antagonist therapy and for the evaluation of hemostasis, as well as to ensure reliable results comparable with those obtained by routine medical laboratory testing.
CLSI POCT14
Original price was: $180.00.$90.00Current price is: $90.00.
Point-of-Care Monitoring of Anticoagulation Therapy; Approved Guideline, POCT14AE
Clinical and Laboratory Standards Institute , 07/27/2020
Related products
-
CLSI M50-P
Original price was: $152.00.$76.00Current price is: $76.00. -
CLSI LA04-A5
Original price was: $247.00.$123.00Current price is: $123.00. -
CLSI I06A
Original price was: $180.00.$90.00Current price is: $90.00. -
CLSI EP15-A2
Original price was: $178.00.$89.00Current price is: $89.00. -
CLSI QMS09-A2
Original price was: $128.00.$64.00Current price is: $64.00.